Latest Gliknik Inc. Stories

2014-02-19 08:34:16

- Jeffrey Herpst joins Baltimore-based Gliknik Inc. to advance mid-stage clinical drug candidates in Gliknik's innovative immunomodulator program - BALTIMORE, Feb. 19, 2014 /PRNewswire/ -- Gliknik Inc., a privately held biopharmaceutical company, today announced that it has expanded its team by adding a new Senior Director of Clinical Development and electing two new members to its Board of Directors. Gliknik is deepening its clinical staff and allocating resources to further...

2011-01-05 09:42:00

BALTIMORE, Jan. 5, 2010 /PRNewswire/ -- Gliknik Inc., a biopharmaceuticals company creating new cancer and immune disorder therapies, today announced an equity financing completed at a premium price. In the past seven months the company has raised $3.5 million in equity financing. Gliknik expects to use the funds to initiate a clinical program in autoimmune diseases for its lead recombinant candidate from its first-in-class stradomer(TM) platform. "An infusion of investor funding...

2010-06-08 08:00:00

BALTIMORE, June 8 /PRNewswire/ -- Biopharmaceuticals company Gliknik Inc. announced today that the Maryland Health Care Product Development Corporation (MHCPDC) has completed an equity investment in the company. MHCPDC and Gliknik further agreed on June 1, 2010 to undisclosed financial terms, under which the MHCPDC will also make a new equity series investment in Gliknik this summer. The MHCPDC is a supporting organization of the Tech Council of Maryland (TCM). "The MHCPDC board is highly...

Word of the Day
  • Bad luck; misfortune.
  • The smallest amount possible or the most worthless thing.
The word 'ambsace' comes from a Latin word meaning 'both'.